Literature DB >> 24751497

Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert.

Scott T Micek1, Kevin M Heard, Mollie Gowan, Marin H Kollef.   

Abstract

OBJECTIVE: To develop an automated alert aimed at reducing inappropriate antibiotic therapy of serious healthcare-associated infections.
DESIGN: Single-center cohort study from November 2011 to November 2012.
SETTING: Barnes-Jewish Hospital (1,250-bed academic hospital). PATIENTS: A total of 3,616 critically ill patients receiving treatment with antibiotics targeting healthcare-associated infections due to Gram-negative bacteria.
INTERVENTIONS: Upon antibiotic order entry in the ICU for a Gram-negative antibiotic, the antibiotic and microbiologic history for each patient was electronically queried in real time across all 13 BJC HealthCare hospitals. Patients were assigned to the alert group if they had exposure to the same antibiotic class currently being prescribed (cefepime, meropenem, or piperacillin-tazobactam) or had a positive culture isolating a Gram-negative organism with resistance to the prescribed antibiotic in the previous 6 months.
MEASUREMENTS AND MAIN RESULTS: Nine hundred patients (24.2%) generated an alert. Alerted patients were significantly more likely to receive inappropriate antibiotic therapy (7.1% vs. 2.9%; p < 0.001). Based on clinical information available in the alert, 34 of 64 of the alerted patients that received inappropriate therapy (53.1%) could have received an alternative β-lactam antibiotic with in vitro susceptibility to the identified pathogen. Independent predictors (adjusted odds ratio [95% CI]) of inappropriate therapy included alert generation (1.788 [1.167-2.740]; p = 0.008), medical ICU patients (1.528 [1.007-2.319]; p = 0.046), and a pulmonary source of infection (2.063 [1.363-3.122]; p = 0.0001). Patients in the alert group had significantly greater hospital mortality (29.9% vs. 23.6%; p < 0.001) and hospital length of stay (median, 13.1 vs. 10.7 d; p < 0.001) compared with nonalert patients.
CONCLUSIONS: Our results suggest that a simple automated alert could identify more than 40% of critically ill patients prescribed inappropriate antibiotic therapy for healthcare-associated infections. These data suggest that an opportunity exists to employ hospital informatics systems to improve the prescription of antibiotic therapy in ICU patients with suspected healthcare-associated infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751497     DOI: 10.1097/CCM.0000000000000337

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.

Authors:  Jason P Burnham; Michael A Lane; Marin H Kollef
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

2.  [One size does not fit all].

Authors:  S Bercker; S Laudi; S N Stehr
Journal:  Anaesthesist       Date:  2017-10       Impact factor: 1.041

Review 3.  The effectiveness of computerised decision support on antibiotic use in hospitals: A systematic review.

Authors:  Christopher E Curtis; Fares Al Bahar; John F Marriott
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

4.  Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014.

Authors:  Yi Dou; Jingning Huan; Feng Guo; Zengding Zhou; Yan Shi
Journal:  J Int Med Res       Date:  2017-04-26       Impact factor: 1.671

Review 5.  Systematic Review of Medical Informatics-Supported Medication Decision Making.

Authors:  Brittany L Melton
Journal:  Biomed Inform Insights       Date:  2017-03-30

6.  A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long?

Authors:  Thomas P Lodise; Qi Zhao; Kyle Fahrbach; Patrick J Gillard; Amber Martin
Journal:  BMC Infect Dis       Date:  2018-12-05       Impact factor: 3.090

Review 7.  Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.

Authors:  Maria Sanz Codina; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2022-02-25       Impact factor: 5.577

8.  Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Authors:  Jason P Burnham; Jennie H Kwon; Margaret A Olsen; Hilary M Babcock; Marin H Kollef
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-17       Impact factor: 3.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.